GC
IPOs - All articles
-
Emerging IPOs flourish as funds seek growth
Equity capital markets bankers are heralding the success of emerging markets IPOs set to be priced in the coming days and weeks, including the flotations of Russia’s Sovcomflot, Lithuania’s Ignitis, Saudi Arabia’s BinDawood and Kazakhstan’s Kaspi.
-
Chindata to price $540m US IPO high
Chinese data centre operator Chinadata Group Holdings has guided investors to the top of price guidance for its Nasdaq listing, eyeing $540m from the deal, according to a source familiar with matter.
-
Weihai City Commercial Bank kickstarts HK$3.1bn IPO
China’s Weihai City Commercial Bank has launched its Hong Kong IPO and is aiming to raise HK$3.1bn ($397.3m) from the deal.
-
Shanghai greenlights Geely Auto’s Star IPO
Geely Automobile Holdings is one step closer to becoming the first Chinese automaker to debut in the Star market, having received stock exchange approval for a secondary listing in Shanghai.
-
Korea’s Big Hit tops 2020 charts with $820m IPO
South Korea's Big Hit Entertainment, the talent manager behind globally-popular boy band BTS, has sealed the country’s largest listing in three years as investors continue to flock to Korea's IPO market.
-
JD Health files for $3bn Hong Kong listing
JD Health International, the healthcare unit of Chinese e-commerce company JD.com, has submitted an IPO application to Hong Kong’s stock exchange.
-
Kaspi returns to market for second attempt at London IPO
Kaspi, the Kazakh fintech and e-commerce firm, has returned to the IPO market for a second attempt at a London listing after cancelling last year's effort over valuation differences between investors and the sellers. Sources say that gap has been bridged and are confident of listing Kaspi this year.
-
Yangtze Power nets $1.8bn from London listing
China Yangtze Power has raised $1.8bn from a smaller-than-expected offer of Global Depositary Receipts in London, sealing only the third listing through the London-Shanghai Stock Connect scheme.
-
Gaming firm Krafton issues RFP for Korean IPO
Korean video game publisher Krafton has invited local and international banks to pitch for a spot on its IPO.
-
Everest Medicines cracks open $451m Hong Kong IPO
Biopharmaceutical firm Everest Medicines has hit the road for its up to HK$3.5bn ($451m) Hong Kong IPO.
-
Robi Axiata gets nod for record Bangladeshi IPO
Telecom operator Robi Axiata has won approval from Bangladesh’s securities regulator to list for Taka5.2bn ($61.9m), making it the country’s largest IPO.
-
Thai ECM gets fillip as SCG kicks off chunky $1.25bn listing
Thailand’s IPO market got a boost this week with SCG Packaging launching what is set to be the country’s largest listing since Covid-19 hit earlier this year. International and local investors have already swamped the deal, which is expected to raise up to Bt39.5bn ($1.25bn), writes Jonathan Breen.
-
Baozun seals $428m Hong Kong secondary listing
Baozun, a Nasdaq-listed e-commerce solutions provider, raised HK$3.3bn ($427.5m) from its secondary offering in Hong Kong this week, wrapping up the deal on strong international demand.
-
Chindata, Yalla roll out IPOs in volatile markets
Chinese companies Chindata Group Holdings and Yalla Group have kicked off their US IPOs, testing investor appetite at a time when sentiment is weak and major equity markets have taken a hit.
-
Yangtze Power launches Stock Connect listing in London
China Yangtze Power, a Chinese utility company, has launched its listing on the London Stock Exchange, becoming the third company to list in London through the London-Shanghai Stock Connect scheme. The deal is expected to be worth up to $3.4bn.
-
Yangtze Power gets CSRC nod for London listing
China Yangtze Power Co has won approval from the Mainland regulator to push ahead with its IPO on the London Stock Exchange.
-
ZTO Express, Zai Lab wrap up HK secondary listings
Chinese logistics company ZTO Express (Cayman) and biopharmaceutical firm Zai Lab wrapped up their secondary listings in Hong Kong on Tuesday.
-
Genor Biopharma targets $371m from Hong Kong IPO
JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).
-
JD Health eyes $3bn from Hong Kong spin-off
JD Health International, the healthcare arm of Chinese e-commerce firm JD.com, is set to list on Hong Kong’s stock exchange by the end of the year.
-
SCG Packaging readies $1.3bn Thai IPO
SCG Packaging is set to begin investor presentations for its up to Bt39.5bn ($1.26bn) IPO, which will be Thailand’s second largest listing in 2020.
-
Ant wins Shanghai approval for jumbo IPO
Ant Group is one step closer to launching its blockbuster dual listing in the Mainland and Hong Kong, after the Shanghai bourse gave its blessing to the Star market leg of the IPO.
-
Ming Yuan Cloud prices $797m HK IPO at top end
Ming Yuan Cloud Holdings has sealed its Hong Kong listing at the top of the marketed range, netting HK$6.2bn ($796.6m) following a strong turnout from sovereign wealth funds and long-only investors.
-
Neusoft Education Tech kicks off HK$1bn IPO
Neusoft Education Technology, a Chinese private higher education provider, hit the road with its Hong Kong IPO this week, aiming to raise HK$1.04bn ($133.8m).
-
CAMS readies $305m Indian listing
Warburg Pincus-backed Computer Age Management Services, an Indian finance-focused technology firm, is set to launch its IPO of up to Rp22.4bn ($305.2m).
-
Korean stock prices 'irrationally high', warn bankers, as Big Hit launches IPO
Big Hit Entertainment, the label behind hugely popular K-pop boy band BTS, this week launched bookbuilding for an IPO that will be worth as much as W962.6bn ($818.4m). The company is the latest to ride a wave of demand sweeping the country’s stock market, causing an over-heating that is pushing prices dangerously high, said bankers. Jonathan Breen reports.
-
Zai Lab and Baozun add to HK ECM momentum
US-listed Chinese companies Zai Lab and Baozun have kicked off secondary offerings on the Hong Kong Stock Exchange, adding further momentum to the city’s already hot equity capital market.
-
Ming Yuan Cloud to close HK$6bn IPO early
Ming Yuan Cloud Holdings is set to wrap up bookbuilding for its up to HK$6.2bn ($796.7m) Hong Kong IPO on Thursday, following a flood of demand from global investors, according to two sources close to the deal.
-
Huazhu guides investors on HK$6bn listing
Chinese hospitality company Huazhu Group is on track to raise around HK$6.06bn ($781.8m) from its secondary offering in Hong Kong, after sending price guidance to investors.
-
ZTO Express joins hot secondary offering market with $1.6bn deal
Mainland-based logistics company ZTO Express (Cayman) has hit the road with its Hong Kong secondary offering, with two other Chinese US-listed firms hot on its heels.
-
Ming Yuan Cloud launches $796m IPO in Hong Kong
Ming Yuan Cloud Group Holdings, a Chinese property sector-focused software company, has kicked off its Hong Kong IPO worth up to HK$6.2bn ($796.3m).
-
Zai Lab, ZTO Express ready HK secondary listings
US-listed Zai Lab and ZTO Express (Cayman) are set to launch secondary offerings in Hong Kong. Both the companies filed their final listing documents with the city’s bourse.
-
Fulu nabs $115m from Hong Kong listing
Virtual goods platform Fulu Holdings has raised HK$890m ($114.8m) after pricing its IPO at the top of the marketed range, according to a source close to the deal.
-
Neusoft wins approval for Hong Kong listing
Neusoft Education Technology, a private higher education provider, got the go-ahead for its IPO this week from the Hong Kong Stock Exchange.
-
Huazhu Group kicks off HK$7.3bn HK secondary listing
Chinese hospitality company Huazhu Group has launched a secondary offering in Hong Kong, the latest in a growing number of dual listings on the bourse.
-
Marketing firm Joy Spreader Interactive launches $225m HK IPO
Joy Spreader Interactive Technology kicked off its Hong Kong IPO on Thursday, aiming to raise up to HK$1.7bn ($225.2m).
-
Coronavirus drug maker SciClone Pharma eyes Hong Kong IPO
SciClone Pharmaceutical (Holdings), a Chinese biopharmaceutical company that claims to have developed a drug to treat Covid-19, is seeking the greenlight to list in Hong Kong.
-
Citi drops Boqii’s $115m NYSE listing
Chinese pet-focused e-commerce site Boqii Holding filed its listing documents for a US IPO on Tuesday, but Citigroup, one of the original lead banks on the deal, is now no longer in the syndicate.
-
Chinese trio line up for $1bn in US listings
Chindata Group Holdings, iHuman and Yalla Group filed IPO paperwork with the US regulator on Tuesday as they prepare to float on New York stock exchanges.
-
LVMH veteran-led Spac eyes $225m US IPO
Singapore-based special purpose acquisition company (Spac) Aspirational Consumer Lifestyle Corp is looking to raise $225m from a listing on the New York Stock Exchange.
-
Updated: Ant clears up Alibaba ties, business model after SSE questions
Ant Group has tackled more than two dozen questions posed by the Shanghai Stock Exchange ahead of its concurrent jumbo IPOs on the Star market and Hong Kong. The digital payment firm’s ownership structure, especially its ties to Alibaba Group Holding, as well as its business model and use of the listing proceeds were under scrutiny.
-
Ming Yuan Cloud pre-markets Hong Kong IPO
Real estate-focused software company Ming Yuan Cloud Group Holdings has kicked off pre-deal investor education for its Hong Kong listing, according to a senior source close to the transaction.
-
India's Happiest Minds Tech cracks opens Rp7bn IPO
Happiest Minds Technologies kicked off a three-day bookbuilding for its Indian IPO on Monday.
-
Virtual goods platform Fulu launches HK$890m listing
China’s Fulu Holdings hit the market on Monday, opening books for an IPO that could raise up to HK$890m ($114.8m).
-
Yum China guides investors to $2.2bn listing
Yum China, the Mainland-based fast food franchise operator, was eyeing at least HK$17.3bn ($2.2bn) in fresh equity on Friday after giving investors some price guidance for its secondary listing in Hong Kong.
-
Investors fill up on billion-dollar Yum China IPO
Fast food franchise operator Yum China Holdings is cooking a multi-billion-dollar secondary offering in Hong Kong. It is the latest deal in a growing trend that bankers expect will bring more US-listed Chinese companies to the exchange by the the end of 2020, writes Jonathan Breen.
-
Geely Auto drives to Star board for secondary listing
Hong Kong-listed Geely Automobile has filed an application to list on the Shanghai Star board, as it prepares to become the first automaker to float on the bourse.
-
K-pop manager Big Hit Entertainment readies IPO
South Korea’s Big Hit Entertainment, the manager of K-pop boy band BTS, is set to launch an IPO worth up to W962.6bn ($811.7m) later this month.
-
China Resources Mixc Lifestyle, Cheerwin line up HK listings
Property manager China Resources Mixc Lifestyle Services is planning an IPO on Hong Kong’s stock exchange, getting the ball rolling with an application to the bourse this week.
